Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1923 1
1962 1
1963 1
1965 5
1966 2
1967 7
1968 14
1969 24
1970 9
1971 4
1972 5
1973 4
1974 9
1975 20
1976 11
1977 8
1978 17
1979 14
1980 15
1981 18
1982 23
1983 22
1984 52
1985 42
1986 32
1987 37
1988 53
1989 60
1990 41
1991 47
1992 45
1993 46
1994 59
1995 54
1996 72
1997 45
1998 79
1999 73
2000 68
2001 67
2002 76
2003 77
2004 59
2005 80
2006 67
2007 56
2008 70
2009 63
2010 51
2011 68
2012 94
2013 96
2014 88
2015 84
2016 76
2017 93
2018 84
2019 79
2020 96
2021 89
2022 93
2023 46

Text availability

Article attribute

Article type

Publication date

Search Results

2,724 results

Results by year

Filters applied: . Clear all
Page 1
Impact of EGFR-TKI Treatment on the Tumor Immune Microenvironment in EGFR Mutation-Positive Non-Small Cell Lung Cancer.
Isomoto K, Haratani K, Hayashi H, Shimizu S, Tomida S, Niwa T, Yokoyama T, Fukuda Y, Chiba Y, Kato R, Tanizaki J, Tanaka K, Takeda M, Ogura T, Ishida T, Ito A, Nakagawa K. Isomoto K, et al. Among authors: fukuda y. Clin Cancer Res. 2020 Apr 15;26(8):2037-2046. doi: 10.1158/1078-0432.CCR-19-2027. Epub 2020 Jan 14. Clin Cancer Res. 2020. PMID: 31937613
Effects of prior osteoporosis treatment on the treatment response of romosozumab followed by denosumab in patients with postmenopausal osteoporosis.
Ebina K, Etani Y, Tsuboi H, Nagayama Y, Kashii M, Miyama A, Kunugiza Y, Hirao M, Okamura G, Noguchi T, Takami K, Goshima A, Miura T, Fukuda Y, Kurihara T, Okada S, Nakata K. Ebina K, et al. Among authors: fukuda y. Osteoporos Int. 2022 Aug;33(8):1807-1813. doi: 10.1007/s00198-022-06386-y. Epub 2022 Apr 1. Osteoporos Int. 2022. PMID: 35362725
A Randomized Phase II Study Comparing Nivolumab with Carboplatin-Pemetrexed for EGFR-Mutated NSCLC with Resistance to EGFR Tyrosine Kinase Inhibitors (WJOG8515L).
Hayashi H, Sugawara S, Fukuda Y, Fujimoto D, Miura S, Ota K, Ozawa Y, Hara S, Tanizaki J, Azuma K, Omori S, Tachihara M, Nishino K, Bessho A, Chiba Y, Haratani K, Sakai K, Nishio K, Yamamoto N, Nakagawa K. Hayashi H, et al. Among authors: fukuda y. Clin Cancer Res. 2022 Mar 1;28(5):893-902. doi: 10.1158/1078-0432.CCR-21-3194. Clin Cancer Res. 2022. PMID: 34921023 Free PMC article. Clinical Trial.
Resolution does matter.
Ishikawa R, Tanigaki T, Fukuda Y. Ishikawa R, et al. Among authors: fukuda y. Microscopy (Oxf). 2023 Apr 6;72(2):65. doi: 10.1093/jmicro/dfad010. Microscopy (Oxf). 2023. PMID: 36737862 No abstract available.
Levetiracetam versus fosphenytoin as a second-line treatment after diazepam for adult convulsive status epilepticus: a multicentre non-inferiority randomised control trial.
Nakamura K, Marushima A, Takahashi Y, Mochizuki M, Kimura A, Fukuda Y, Asami M, Nakamoto H, Egawa S, Kaneko J, Unemoto K, Kondo Y, Yonekawa C, Uchida M, Hoshiyama E, Yamada T, Maruo K, Ishikawa E, Matsumaru Y, Inoue Y; IENE ECT with the LIFE study group. Nakamura K, et al. Among authors: fukuda y. J Neurol Neurosurg Psychiatry. 2023 Jan;94(1):42-48. doi: 10.1136/jnnp-2022-329485. Epub 2022 Oct 7. J Neurol Neurosurg Psychiatry. 2023. PMID: 36207063 Free PMC article. Clinical Trial.
2,724 results